A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
Clinical trial NCT01081782 · COMPLETED
Trial details
- NCT number
- NCT01081782
- Sponsor
- Ono Pharma USA Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2011-12-01
- Enrollment
- 407
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.